MACROBID
What it isUrinary antiseptic whose reactive intermediates damage bacterial DNA; uncomplicated lower urinary infection.
Why this oneIt concentrates in urine with little systemic or microbiome exposure, so resistance remains relatively uncommon.
What limits itDo not use for pyelonephritis or bacteremia; poor renal function prevents urinary delivery. Long courses risk lung, liver and nerve toxicity.
Read the full label on DailyMed ↗
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Urinary tract infection | Adults & peds >12 yr | 100 mg BID | 100 mg BID | 100 mg BID x7 days |
Renal Contraindicated if CrCl <60 mL/min or significant renal impairment (anuria/oliguria)
Hepatic Contraindicated with prior nitrofurantoin-associated cholestatic jaundice/hepatic dysfunction; otherwise Undefined
Pregnancy Contraindicated at term (38-42 wk), during labor/delivery, or when labor imminent (neonatal hemolytic anemia risk)
Lactation Undefined
NO BOXED WARNINGS
Principal riskPulmonary toxicity with long-term use; ineffective in pyelonephritis
Cost, est. cash$10–$500/month
Generic entry2011
Legacy pregnancy categoryB
Defining liabilityAllergy, gastrointestinal effects and agent-specific renal, hepatic, hematologic or interaction risks.

Open Nitrofurantoin in the interactive console ↗

